Sagent announced a voluntary nationwide recall of 3 lots of Ketorolac Tromethamine Injection manufactured by Cadila Healthcare Limited. This recall is due to an incorrect expiration date on the product labeling that indicates a longer time than the known stability of the drug.
The affected 30mg/mL products contain Lot # MP5021, MP5024, and MP5025, which were distributed to hospitals, wholesalers, and distributors from September 17 to October 1, 2014. They are supplied in single-dose vials with NDC 25021-701-01 and 25021-701-02.
Ketorolac Tromethamine Injection is a nonsteroidal anti-inflammatory drug (NSAID) that is indicated for short-term management of moderately severe acute pain requiring analgesia at the opioid level, usually in a postoperative setting.
Sagent is notifying customers through fax, email, FedEx, and/or certified mail for an arrangement of all recalled products.
For more information call (866) 625-1618 or visit SagentPharma.com.